Patent classifications
C12N2501/2308
Method of preparing in vitro-matured human intestinal organoids and use thereof
Provided are a method of preparing in vitro-matured intestinal organoids, and intestinal organoids prepared by the method.
PRECURSORY REGULATORY CYTOTROPHOBLAST CELLS AND USES THEREOF
Disclosed herein are precursory regulatory cytotrophoblast cells produced in vitro and compositions thereof. Disclosed herein are isolated populations of precursory regulatory cytotrophoblast cells, wherein the cells are produced in vitro. Disclosed herein are genetically engineered cells. Also disclosed herein are methods of treating a disorder or condition by utilizing the cells disclosed herein.
METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN
A method of using factor rich product from umbilical cord mesenchymal stem cells to increase collagen and elastin in adult human skin.
Cancer-killing cells
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
Lyophilized compositions containing umbilical cord lining stem cells conditioned medium
Factor rich compositions produced from umbilical cord (UC) mesenchymal stem cells (MSCs) are described. Secretory UC MSCs in serum free culture conditions produce a factor rich conditioned medium which may be concentrated and filtered to obtain clinical grade products.
CANCER-KILLING CELLS
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS
The present invention provides a method for producing recombinant growth factors using an algal expression system, which offers advantages over traditional platforms, and the algae-derived growth factors can be used to formulate cell culture media for mammalian cells without the risk of pathogen contamination or endotoxins.